Is early loss of minimal luminal diameter after successful PTCA prevented by c7E3 IIb/IIIa antiplatelet antibody?

被引:0
|
作者
Leon, MN [1 ]
Gold, HK [1 ]
Mahdi, NA [1 ]
Harrell, L [1 ]
Rodriguez, A [1 ]
Palacios, IF [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1016/S0735-1097(97)83945-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:55A / 55A
页数:1
相关论文
共 49 条
  • [1] CORONARY STENTING DECREASES RESTENOSIS IN LESIONS WITH EARLY LOSS IN LUMINAL DIAMETER 24 HOURS AFTER SUCCESSFUL PTCA
    RODRIGUEZ, AE
    SANTAERA, O
    LARRIBAU, M
    FERNANDEZ, M
    SARMIENTO, R
    BALINO, NP
    NEWELL, JB
    ROUBIN, GS
    PALACIOS, IF
    CIRCULATION, 1995, 91 (05) : 1397 - 1402
  • [2] Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA)
    Zahn, R
    Haubelt, H
    Bechtloff, S
    Schneider, S
    Frilling, B
    Rustige, J
    Marsalek, P
    Seidl, K
    Senges, J
    Hellstern, P
    HERZ, 2003, 28 (05) : 445 - 452
  • [3] Free and total platelet glycoprotein IIb IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA
    Hézard, N
    Metz, D
    Nazeyrollas, P
    Nguyen, P
    Simon, G
    Daliphard, S
    Droullé, C
    Elaerts, J
    Potron, G
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 869 - 873
  • [4] Platelet glycoprotein IIb/IIIa monoclonal antibody (c7E3) inhibits restenotic smooth muscle cell migration and induces apoptosis
    Bauriedel, G
    Hutter, R
    Brill, C
    Schluckebier, S
    Heidemann, P
    Luderitz, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7902 - 7902
  • [5] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    H. Stiegler
    Y. Fischer
    S. Steiner
    B. E. Strauer
    H. Reinauer
    Annals of Hematology, 2000, 79 : 161 - 164
  • [6] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    Stiegler, H
    Fischer, Y
    Steiner, S
    Strauer, BE
    Reinauer, H
    ANNALS OF HEMATOLOGY, 2000, 79 (03) : 161 - 164
  • [7] ANTIPLATELET GPIIB/IIIA (7E3) ANTIBODY IN ELECTIVE PTCA - SAFETY AND INHIBITION OF PLATELET-FUNCTION
    ELLIS, SG
    NAVETTA, FI
    TCHENG, JT
    WEISMAN, HF
    WANG, AL
    PITT, B
    TOPOL, EJ
    CIRCULATION, 1990, 82 (04) : 191 - 191
  • [8] Evidence for a decreased thrombin generation after platelet glycoprotein IIb/IIIa receptor antagonist c7E3 FAB infusion.
    Musso, R
    Cabibbo, S
    Cultrera, D
    Russo, M
    Russo, G
    Nicosia, A
    Mammana, C
    Tamburino, C
    Giustolisi, R
    BLOOD, 1997, 90 (10) : 1321 - 1321
  • [9] Successful reperfusion in acute myocardial infarction by single bolus injection of the GPIIb/IIIa-receptor antibody c7E3 (abciximab)
    Domanovits, H
    Nikfardjam, M
    Gamper, G
    Schreiber, W
    Janata, K
    GottsaunerWolf, M
    Laggner, AN
    Huber, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2721 - P2721
  • [10] RATIONAL USE OF CORONARY STENTING TO PREVENT RESTENOSIS - A RANDOMIZED STUDY IN LESIONS WITH EARLY MINIMAL LUMINAL DIAMETER LOSS AFTER PTCA
    RODRIGUEZ, A
    SANTAERA, O
    LARRIBAU, M
    FERNANDEZ, M
    RICCITELLI, M
    BALINO, NP
    PALACIOS, IF
    ROUBIN, GS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A118 - A118